Market Overview

Genprex to Present at the 11th Annual LD Micro Main Event


Presentation Wed., Dec. 5, 2018, at 10:30 a.m. PST

Genprex, Inc. (NASDAQ:GNPX), a clinical-stage gene therapy company
developing a new approach to treating cancer based upon a novel
proprietary technology platform, announced today that its Chairman and
Chief Executive Officer, Rodney Varner, will present at the 11th annual
LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles,

Genprex is scheduled to present on Wed., Dec. 5, 2018, at 10:30 a.m.
PST. Genprex management will also attend one-on-one meetings with
institutional investors throughout the day.

The LD Micro Main Event is the largest independent conference for
small/micro-cap companies and will feature 250 companies presenting to
an audience of over 1,200 attendees.

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing a new
approach to treating cancer, based upon a novel proprietary technology
platform, including Genprex's initial product candidate, Oncoprex™
immunogene therapy for non-small cell lung cancer (NSCLC). Genprex's
platform technologies are designed to administer cancer fighting genes
by encapsulating them into nanoscale hollow spheres called nanovesicles,
which are then administered intravenously and taken up by tumor cells
where they express proteins that are missing or found in low quantities.
Oncoprex has a multimodal mechanism of action whereby it interrupts cell
signaling pathways that cause replication and proliferation of cancer
cells, re-establishes pathways for apoptosis, or programmed cell death,
in cancer cells, and modulates the immune response against cancer cells.
Oncoprex has also been shown to block mechanisms that create drug
resistance. Visit the company's web site at
or follow Genprex on Twitter at
and Facebook at

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an
independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into several
influential events annually (Invitational, Summit, and Main Event). In
2015, LDM launched the first pure microcap index (the LDMi) to
exclusively provide intraday information on the entire sector. LD will
continue to provide valuable tools for the benefit of everyone in the
small and micro-cap universe.

For those interested in attending, please contact David Scher at
or visit
for more information.

View Comments and Join the Discussion!